Skip to content

YNIOS Pharma

Active
Private limited companyfounded 20224 yrs activeAvenue Wolfers 32, 1310 La Hulpe, BelgiumKBO/BCE: BE 0783.494.239
Summary

The computed 12-month bankruptcy probability of YNIOS Pharma is 3.1% (moderate). The 2025 annual accounts show equity of €473,563 and a net result of -€228,903. Equity is growing by ~60.6% per year across the filed fiscal years. Its solvency ranks better than 70% of 145 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
YNIOS PharmaActiveChecked score 49/100
Risk analysis ReportCompare

Articles of association

Other provisionsOther rules from the articles that fall under none of the themes above.
Other statement: Transfert du siège social par l'organe d'administration, n'entraîne pas de changement de langue des statuts

Read from the deeds: 1 provision, deed of 08-07-2026

We would like to set cookies. That happens only with your consent. What we measure